Infectious Diseases Institute (IDI)
The Infectious Diseases Institute (IDI) is a Ugandan not-for-profit organization whose mission is to strengthen health systems in Africa, with strong emphasis on infectious diseases, through research and capacity development. IDI has six operational areas through which it works to achieve its mission: Prevention, Care and Treatment; Training, Research, Laboratory services (including the CAP-certified IDI Core Lab & Translational Lab), Global Health Security and Health System Strengthening.
Students intending to pursue their internships with IDI and volunteers should submit their applications through this HR online application Portal.
Please follow the link to register for Internship or Volunteering, or login.
Available Job Opportunities
Job Description 2: Postdoctoral Fellow in Pathogen Genomics (One Health Focus)
- Position Title: Postdoctoral Fellow – Pathogen Genomics
- Department: Global Health Security
- Project: Professor Sewankambo Global Health Security Training Program in Africa
- Reports To: Deputy Head of Department
- Duration: One year, renewable
- Location: IDI-McKinnell MKC, Makerere University Campus
- Application Deadline: Two weeks after the advert date
Position Overview
We are seeking a dynamic Postdoctoral Fellow with expertise in pathogen genomics to strengthen our global health security program, with a particular emphasis on One Health approaches. The role integrates genomics applications with practical contributions to business development, scientific documentation, and program implementation to combat infectious diseases at the human-animal-environment interface.
1
MKC
Scholar
6 Months
Deputy Head of Department
2026-09-24 09:56:39.000
ACCEPT-Africa Targeted Research Awards for Epidemic and Pandemic Preparedness
Background
The African Consortium for Clinical Evidence, Pharmacology and Translational Research (ACCEPT-Africa) is a multidisciplinary, multi-country research consortium under the Africa Pandemic Sciences Collaborative (EPSILON-1). Led by the Infectious Diseases Institute (IDI), Makerere University, Uganda, ACCEPT-Africa brings together research institutions and investigators from Uganda, Tanzania (Kibong’oto Infectious Diseases Hospital), the Democratic Republic of Congo (Catholic University of Bukavu), South Africa (University of Cape Town), and Italy (University of Turin) to strengthen Africa's capacity to develop, evaluate, and deploy medical countermeasures for epidemic- and pandemic-prone diseases.
ACCEPT-Africa integrates expertise in early-phase clinical trials, clinical pharmacology, pharmacokinetics/pharmacodynamics (PK/PD), implementation science, infectious diseases, laboratory sciences, regulatory science, and epidemic preparedness.
The consortium is guided by three strategic objectives:
- Advance the clinical development of medical countermeasures targeting priority pathogens;
- Strengthen epidemic–pandemic research ecosystems; and
- Build sustainable capacity for early-phase clinical trials targeting priority pathogens.
To advance these objectives, ACCEPT-Africa invites applications from individual researchers for Targeted Research Awards addressing priority scientific and operational gaps relevant to medical countermeasure development and epidemic clinical research.
Purpose of the Call
The ACCEPT-Africa Targeted Research Awards will provide catalytic funding for focused, high-impact and implementation-oriented research projects that can generate preliminary evidence, address critical knowledge or methodological gaps, strengthen existing research platforms, and contribute to the development and evaluation of medical countermeasures for priority pathogens.
A total of three awards will be available, with funding of up to US$15,000 per project for an implementation period of up to 12 months.
The call is specifically intended to support research that can leverage existing ACCEPT-Africa platforms, cohorts, protocols, laboratory capabilities, partnerships and research infrastructure to achieve clearly defined outputs within the award period.
Applicants must submit a proposal addressing one of the three priority research areas below.
Priority Research Areas
Priority Area 1: Pharmacokinetics of drugs used for diseases of outbreak potential
Priority Area 2: Biomarkers and diagnostics for drug development which could be viral, immunological or other markers that can be used to assess treatment response or severity of highly infectious diseases of outbreak potential
Priority Area 3: Social and Behavioral Research on Epidemic Clinical Trials
Funding Available
ACCEPT-Africa intends to make three competitive research awards, subject to satisfactory scientific review and availability of funds.
Maximum Award
Each successful project may receive funding of up to US$15,000.
Applicants are expected to submit realistic and well-justified budgets directly linked to the proposed research activities and outputs.
Eligible costs may include research personnel support, laboratory reagents and consumables, sample processing and analysis, data collection, participant-related research costs, field activities, data management and analysis, stakeholder/community engagement directly related to the research, and dissemination of findings.
Major capital equipment and costs not directly attributable to delivery of the proposed research should generally not constitute a substantial proportion of the requested budget.
Application Requirements
Applicants should submit a concise application package containing:
- CV and personal statement (use the NIH template)
- 2 letters of recommendations (ACCEPT-Africa site PI and one proposed mentor)
- Proposal (download the template.docx)
- Budget (maximum US$15,000)
Key Timelines
|
Milestone |
Date/Period |
|
Call opens |
September 2026 |
|
Application deadline |
16th October 2026 |
|
Scientific and technical review |
November 2026 |
|
Notification of successful applicants |
Late November 2026 |
|
Anticipated project commencement |
December 2026 |
Applications must be received by 16th October 2026. Late or substantially incomplete applications will not be considered.
3
Mulago
Scholar
12 Months
Capacity Building Scientist
2026-09-23 14:42:11.000